Latest news & events
5 News - Global warning over resistance of antibiotics to superbugs
May 19, 2016
If the world doesn't take action now, superbugs will kill someone every three seconds within a generation. That's the stark warning from a global study into antibiotics, which says we're overusing them and failing to develop enough new ones. The report says in future, basic procedures we take for granted could become too dangerous to carry out.
The battle against drug resistant infection
May 19, 2016
The battle against infections that are resistant to drugs has been described as "big a risk as terrorism", according to a new report. The Review on Antimicrobial Resistance says superbugs will kill someone every three seconds by 2050 unless the world acts now. Joanna Gosling spoke to Professor Laura Piddock, who advised on the report, Yvonne Smith, who lost her father to a superbug infection, Derek Butler, from charity MRSA Action UK, Sharon Brenan, a transplant patient and health journalist and Professor Paul Cosford from Public Health England. More...
MRSA Action UK: With 10 million people predicted to die every year from resistant infections by 2050 we cannot afford to wait 30-50 years before action is taken on Antimicrobial Resistance – Response to the O’Neill Report
19 May 2016
Chair and spokesperson for MRSA Action UK Derek Butler was invited on BBC 2’s Victoria Derbyshire current affairs program to discuss the release of Lord O’Neill’s report commissioned by the Prime Minister David Cameron on Antimicrobial Resistance (AMR). The report and the lack of the pharmaceutical companies’ ability or incentive to develop new treatments for the ever growing resistance to antibiotics were featured in the report. Lord O’Neill’s report highlighted concern regarding the growing threat to human health from AMR for future generations. The report cites reducing unnecessary use of antimicrobial drugs in healthcare settings; monitoring and reducing superfluous use of the drugs in farming; banning or restricting antibiotics that are vital for human health from being used in animals; using diagnostic tools to reduce inappropriate prescribing; a global public awareness campaign about the problem of drug resistance and increasing the supply of new antibiotic drugs. More...
MRSA & MSSA at its highest for 5 years
19 May 2016
Although progress has been made since mandatory reporting of MRSA has been introduced, this bacteria shows resilience and despite best efforts trends for the last 5 years show an increase. In 2011/12 there were 472 hospital reported bloodstream infections, this reduced by 16% the following year to 398, however the trend is now increasing, and 5 years on there is an overall increase of 11%, with the most significant increase seen in 2015/16, a 21% increase over the year with 520 cases. The rise in numbers coincides with the Department of Health’s change in policy on screening for MRSA, from universal screening to targeted screening.
MSSA bloodstream infections are at their highest levels for 5 years, increasing by 4% over the last year, and 2% since 2011/12 with 2,910 cases reported. These infections are sensitive to Meticillin related antibiotics but still cause significant morbidity and mortality in vulnerable patients.
Staphylococcus aureus is a pathogen that we live with every day and is proving to be a significant challenge in and outside of hospital. There has been a 37% drop in the numbers of MRSA bloodstream infections reported in the primary care setting over the last 5 years with 1,116 cases reported in 2011/12 down to 818 cases in 2015/16, but the trend in reductions halted in 2014/15 and a 3% increase was seen over the last year.
MSSA bloodstream infections have shown an increasing trend over the last 5 years. There were 8,767 cases reported in the primary care setting rising by 18% to 10,587 in 2015/16. It is unclear from the surveillance what proportion were attributed to lapses in care or unrelated to healthcare, but in terms of tackling antibiotic resistance, a worrying trend if more antibiotics are needed to tackle the infections.
Clostridium difficile remains a challenge, reductions over the last 5 years were significant, with a 48% reduction in hospital cases and 27% reduction in primary care. However, the reducing trend has stalled. The highest proportion of cases are in primary care where antibiotic prescribing is likely to be one of the most significant contributing factors. For hospitals prescribing, environmental cleaning, hand hygiene and keeping a check on the epidemiology (strain) of the infection is important. Some strains of Clostridium difficile are more difficult to treat, tracing the strain can also assist with identification of infection control lapses and inappropriate prescribing. Post infection review needs to be used effectively to tackle the high numbers of infections.
MRSA Action UK believe that post infection review should be carried out not only for MRSA bloodstream infections, but for surgical site infections, we do not know how many people suffer as a consequence of these as these are still not recorded effectively to be able to compare and assess the best way to avoid them.
Public Health England has made information available on mandatory reporting and antimicrobial resistance in the health profile portal, which is accessible to the public. To find out how your area is performing visit Public Health England’s Antimicrobial Resistance pages.
Jules and Steve make a great return to the Colchester Half Marathon
13 March 2016
Jules and Steve completed their first race of the year in the Colchester Half Marathon. They had a break of 3 months, but undaunted they both finished in 2 hours. The race broke records with thousands of runners taking part in the spring sunshine.
You smashed it again Jules and Steve! Thanks again for all you do for MRSA Action UK.
To support Jules and Steve leave a message on their Just Giving page visit http://www.justgiving.com/JulesnSteve
or text MRSA66 to 70070 and the amount to donate
To see read about their races and achievements visit Jules and Steve's page
23 February 2016
The Brewery, Chiswell Street, London
Derek Butler a founding member and chair of MRSA Action UK, chaired the inaugural Infection Prevention & Control Conference, hosted by Knowlex. This opportunity to highlight the effect that healthcare-associated infections have on patients and their families, kept the conference focused on the patient. More.....
A Practical Guide to improving practice and monitoring compliance against The NICE Quality Standard for Healthcare Associated Infections
Wednesday 20 April 2016, ICO Conference Centre, London
The NICE Quality Standard for Healthcare Associated Infection (February 2016)
Dr Bharat Patel, Consultant Microbiologist
Specialist Committee Member, Healthcare Associated Infections, Prevention and Control Quality Standard, NICE
- the evidence on what works and what is avoidable
- setting and appraising clear objectives for all hospital staff in relation to infection prevention and control: developing annual appraisal for HAI
- priority areas for improvement
- monitoring implementation from a provider and commissioner perspective
- challenges in practice
HAI Surveillance and monitoring: what needs to change?
Dr Theresa Lamagni, Senior Epidemiologist, Healthcare Associated Infection & Antimicrobial Resistance Department, Public Health England
Meeting Statement 1: Hospitals monitor the incidence of healthcare-associated infections, and the risk of infections in hospitals from community-wide outbreaks, to inform multi-agency action when alerts are identified.
- managing monitoring and surveillance in practice
- mandatory and voluntary reporting
- effectively monitoring incidents and trends
- identifying potential risks from community-wide outbreaks
- current issues and challenges
The ‘Power’ of the Patient - Involving patients to reduce HAI
Derek Butler Chairman, MRSA Action UK
- Why involve patients?
- The Good story, the Bad story and what makes the difference
Admission, Discharge and Transfer
Prof Brian Duerden CBE Inspector of Microbiology and Infection Control Department of Health
Meeting Statement 4: People admitted to, discharged from or transferred between hospitals have information about any infections and associated treatments shared with their health and social care practitioners.
- ensuring people admitted to, discharged from or transferred between hospitals have information about any infections and associated treatments shared with their health and social care practitioners
- how can we improve the sharing of information and collaboration across health and social care organisations?
- our experience and moving forward
Interventions to Improve Antimicrobial Prescribing in Hospital Care: What works?
Professor Jonathan Cooke
- what interventions work to improve antimicrobial prescribing: the evidence
- changing culture and practice
- what he future holds
Tameside Hospital Infection Control Study Day
Tameside General Hospital, Ashton-Under-Lyne
Thursday 5 May 2016
Derek Butler, Chair of MRSA Action UK, will attend to present 'The Future of Infection Prevention & Control' delivering key messages for staff, featuring patient stories.
IPCC Infection Prevention & Containment Conference
12 May 2016
An estimated 4.1m European patients are affected by Healthcare Acquired Infections (HCAIs) every year. Increasing resistance of bacteria to existing drugs and a lack of new antibiotics is a major concern for all healthcare institutions. The Infection Prevention and Containment Conference looks at the future impact of this issue and how best practice in the areas of hand hygiene, compliance, monitoring, room sterilisation and water treatment can be used to fight the causes of HCAIs.
AHCP - Association for Healthcare Cleaning Professionals Conference
9 & 10 June 2016
The 2016 event promises to deliver two extremely valuable and informative days along with great networking opportunities. With the ongoing pressures to deliver more for less, the 2016 conference theme, Healthcare Cleaning, Delivering Under Pressure, will help you find the answers you are looking for to take back to your workplace and also allow you to share your own knowledge to help others.
Salford Professional Development
The Future of Infection Prevention & Control Conference
London 7 July 2016
Join us for The Future of Infection Prevention and Control Conference, where expert speakers from government, health care, academia and the private sector will be presenting their views on how to address the threat of antimicrobial resistance. Topics covered will include how antimicrobial resistance is spread, how ‘superbugs’ could decrease the effectiveness of modern medicine and what action can be taken to combat antimicrobial resistance before it is too late.